I. MODIFIED AGREEMENTS | |||
Company* |
Company* |
Change from | Terms/Details (Date) |
| | |||
Cytomedix |
Harvest Technologies Inc.* |
They resolved litigation related to Cytomedix's platelet gel technology |
A license has been granted to Harvest as part of the settlement; further terms were not disclosed (5/24) |
NiKem Research |
Hybrigenics |
They expanded and extended a research services agreement |
NiKem will continue to provide medicinal chemistry services to optimize inhibitors of ubiquitin-specific proteases for use as cancer agents (5/9) |
| | |||
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
OTC BB = Over-the-Counter Bulletin Board. | |||
